No abstract available.
Allergens*

Using tests in vivo and in vitro to assess potency of Candida albicans allergen in 6 lots of rats with 250 - 300g in bodyweight, each lot had 10 rats. Results: anaphylactic value was 3.4±0.04, mastocyte test, prick test and stimulatory test had highly positive rates. Aandida Albicans allergen is one of the rhinitis inducing allergens that have high positive rate of tests: prick test 55.36%, stimulatory test 87.10%. Candida albicans allergen can be used for specific diagnosis in subjects, who are suspected of allergy with Candida albicans
Candida albicans ; Allergens

The study uses combining allergen preparation process of Coca and Sutherland method to prepare feather allergen with efficiency of 1.87g%. The allergen composes 16 amino acids, among that cyclic ones are of 19.25% and total nitrogen protein levels are 11,940 PNU (1/500 solution). The produced allergen has low toxicity, so it is safe for use
Allergens ; Candida albicans

No abstract available.
Allergens ; Rhinitis, Allergic

No abstract available.
Allergens ; Anaphylaxis ; Humans ; Infant

Allergen-specific Th2 cells refer to a subset of Th2 cells that undergo substantial expansion following allergen stimulation. They play a crucial role in allergic diseases, and an increasing amount of research has revealed a close relationship between surface molecules on allergen-specific Th2 cells and allergic diseases. In comparison to other CD4+T cells or Th2 cells, allergen-specific Th2 cells exhibit low expression of CD27 but high expression of CD154, CD69, CRTH2, CD161, ST2, hPGDs, CD49d, and COX-2. They can be used for the identification of allergen-specific Th2 cells and serve as potential targets for the prevention and treatment of specific diseases. They hold significant value in preventing the onset and exacerbation of allergic diseases.
Humans ; Allergens ; Th2 Cells

Allergen-specific Th2 cells refer to a subset of Th2 cells that undergo substantial expansion following allergen stimulation. They play a crucial role in allergic diseases, and an increasing amount of research has revealed a close relationship between surface molecules on allergen-specific Th2 cells and allergic diseases. In comparison to other CD4+T cells or Th2 cells, allergen-specific Th2 cells exhibit low expression of CD27 but high expression of CD154, CD69, CRTH2, CD161, ST2, hPGDs, CD49d, and COX-2. They can be used for the identification of allergen-specific Th2 cells and serve as potential targets for the prevention and treatment of specific diseases. They hold significant value in preventing the onset and exacerbation of allergic diseases.
Humans ; Allergens ; Th2 Cells

Study on specific desensitive treatment for Dermatophagodes pteronyssinus allergen in 33 patients (mean age: 33.73+/-10.98) with allergic rhinitis at Central Otorhinolaryngology Hospital from November 2003 to October 2004. After treatment, all of clinical symptoms were reduced. Common effects on clinical treatmen were excellent in 24.3%, good in 45.5%, moderate 15.1% and bad in 15.1%. Before treatment, 100% patients had positive nose stimulation test and by 6 months of treatment, the rate only was 9.1%. After treatment, total IgE level in serum was lower than before treatment and total IgG level in serum was increased in comparison with before treatment. Common results after treatment: excellent 24.2%, good 48.5%, moderatel18.2% and bad 9.1%
Dermatophagoides pteronyssinus ; Rhinitis ; Hypersensitivity ; Allergens

Allergens ; immunology ; Desensitization, Immunologic ; Humans

This article is the second part of the consensus. The principle of allergic diseases treatment is "combination of prevention and treatment, four in one":environmental control can avoid or reduce allergens, which is the first choice; allergen vaccine desensitization treatment is a cause-response treatment and has been considered as the first-line treatment; targeting drugs to block allergy or anti-allergy drugs to control symptoms is a commonly used symptomatic treatment method, which needs to be used with reference to the management of chronic diseases; Health education can change patients' misconceptions, improve their initiative and compliance, change their behavior, and improve the efficacy.
Humans ; Consensus ; Allergens ; Patient Compliance